179 related articles for article (PubMed ID: 31713940)
1. The role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control study.
Busby J; Karasneh R; Murchie P; McMenamin Ú; Gadalla SM; Camargo MC; Iversen L; Lee AJ; Spence AD; Cardwell CR
Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):48-56. PubMed ID: 31713940
[TBL] [Abstract][Full Text] [Related]
2. The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
Busby J; Murchie P; Murray L; Iversen L; Lee AJ; Spence A; Watson MC; Cardwell CR
Int J Cancer; 2017 Apr; 140(8):1828-1835. PubMed ID: 28120338
[TBL] [Abstract][Full Text] [Related]
3. Use of anti-androgenic 5α-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.
Rabbani S; Santoni G; Lagergren J; Xie SH
Br J Cancer; 2022 Sep; 127(5):892-897. PubMed ID: 35715630
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
Busby J; McMenamin Ú; Spence A; Johnston BT; Hughes C; Cardwell CR
Aliment Pharmacol Ther; 2018 Jan; 47(2):279-288. PubMed ID: 29105106
[TBL] [Abstract][Full Text] [Related]
5. Exposure to weak opioids and risk of gastrointestinal tract cancers: A series of nested case-control studies.
Houston MG; McMenamin Ú; Johnston B; McDowell RD; Hughes CM; Murchie P; Cardwell CR
Br J Clin Pharmacol; 2023 Sep; 89(9):2757-2766. PubMed ID: 37117154
[TBL] [Abstract][Full Text] [Related]
6. Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.
Spence AD; Busby J; Murchie P; Kunzmann AT; McMenamin ÚC; Coleman HG; Johnston BT; O'Rorke MA; Murray LJ; Iversen L; Lee AJ; Cardwell CR
Int J Cancer; 2018 Jul; 143(1):22-31. PubMed ID: 29396851
[TBL] [Abstract][Full Text] [Related]
7. Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
García Rodríguez LA; Soriano-Gabarró M; Vora P; Cea Soriano L
Int J Cancer; 2020 Nov; 147(9):2394-2404. PubMed ID: 32329063
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
9. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
García Rodríguez LA; Lagergren J; Lindblad M
Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
[TBL] [Abstract][Full Text] [Related]
10. Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride.
Bird ST; Brophy JM; Hartzema AG; Delaney JA; Etminan M
J Urol; 2013 Nov; 190(5):1811-4. PubMed ID: 23665270
[TBL] [Abstract][Full Text] [Related]
11. Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study.
Rabbani S; Mattsson F; Lagergren J; Xie S
Acta Oncol; 2023 May; 62(5):438-443. PubMed ID: 37216488
[TBL] [Abstract][Full Text] [Related]
12. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
Ljung R; Martin L; Lagergren J
Eur J Cancer; 2011 Sep; 47(14):2128-32. PubMed ID: 21489778
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of Oesophageal Squamous-Cell Carcinoma and Adenocarcinoma: A Multicentre Retrospective Cohort Study.
Arai J; Niikura R; Hayakawa Y; Kawahara T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Ikeya T; Arai M; Suzuki N; Tsuji Y; Yamada A; Kawai T; Koike K
Digestion; 2022; 103(3):192-204. PubMed ID: 34929693
[TBL] [Abstract][Full Text] [Related]
14. Motor vehicle exposure and risk of oesophageal adenocarcinoma.
Lagergren J; Jansson C; Lu Y
Eur J Cancer; 2011 Jul; 47(10):1446-9. PubMed ID: 21570825
[TBL] [Abstract][Full Text] [Related]
15. Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors.
Mäkelä VJ; Kotsar A; Tammela TLJ; Murtola TJ
J Urol; 2018 Oct; 200(4):743-748. PubMed ID: 29730200
[TBL] [Abstract][Full Text] [Related]
16. A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial.
Guo W; Blot WJ; Li JY; Taylor PR; Liu BQ; Wang W; Wu YP; Zheng W; Dawsey SM; Li B
Int J Epidemiol; 1994 Jun; 23(3):444-50. PubMed ID: 7960367
[TBL] [Abstract][Full Text] [Related]
17. Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma.
Jansson C; Plato N; Johansson AL; Nyrén O; Lagergren J
Occup Environ Med; 2006 Feb; 63(2):107-12. PubMed ID: 16421388
[TBL] [Abstract][Full Text] [Related]
18. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
[TBL] [Abstract][Full Text] [Related]
19. Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).
Collins GS; Altman DG
Eur J Cancer; 2013 Mar; 49(5):1040-8. PubMed ID: 23159533
[TBL] [Abstract][Full Text] [Related]
20. A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance.
Zager MG; Barton HA
PLoS One; 2012; 7(9):e44359. PubMed ID: 22970204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]